Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus.
Sci Rep
; 11(1): 19458, 2021 09 30.
Article
en En
| MEDLINE
| ID: mdl-34593911
Efficacious therapeutics for Ebola virus disease are in great demand. Ebola virus infections mediated by mucosal exposure, and aerosolization in particular, present a novel challenge due to nontypical massive early infection of respiratory lymphoid tissues. We performed a randomized and blinded study to compare outcomes from vehicle-treated and remdesivir-treated rhesus monkeys in a lethal model of infection resulting from aerosolized Ebola virus exposure. Remdesivir treatment initiated 4 days after exposure was associated with a significant survival benefit, significant reduction in serum viral titer, and improvements in clinical pathology biomarker levels and lung histology compared to vehicle treatment. These observations indicate that remdesivir may have value in countering aerosol-induced Ebola virus disease.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Antivirales
/
Adenosina Monofosfato
/
Fiebre Hemorrágica Ebola
/
Alanina
/
Ebolavirus
Límite:
Animals
Idioma:
En
Revista:
Sci Rep
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos